Correlating Bladder Cancer Risk Genes with Their Targeting MicroRNAs Using MMiRNA-Tar

被引:6
|
作者
Liu, Yang [4 ]
Baker, Steve [3 ]
Jiang, Hui [5 ]
Stuart, Gary [1 ,2 ]
Bai, Yongsheng [1 ,2 ]
机构
[1] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA
[2] Indiana State Univ, Ctr Genom Advocacy, Terre Haute, IN 47809 USA
[3] Indiana State Univ, Dept Math & Comp Sci, Terre Haute, IN 47809 USA
[4] Rose Hulman Inst Technol, Dept Elect & Comp Engn, Terre Haute, IN 47803 USA
[5] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
关键词
EXPRESSION PROFILES; MUTATIONS; RNA; ASSOCIATION; MIRNA;
D O I
10.1016/j.gpb.2015.05.003
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
The Cancer Genome Atlas (TCGA) (http://cancergenome.nih.gov) is a valuable data resource focused on an increasing number of well-characterized cancer genomes. In part, TCGA provides detailed information about cancer-dependent gene expression changes, including changes in the expression of transcription-regulating microRNAs. We developed a web interface tool MMiRNA-Tar (http://bioinf1.indstate.edu/MMiRNA-Tar) that can calculate and plot the correlation of expression for mRNA-microRNA pairs across samples or over a time course for a list of pairs under different prediction confidence cutoff criteria. Prediction confidence was established by requiring that the proposed mRNA-microRNA pair appears in at least one of three target prediction databases: TargetProfiler, TargetScan, or miRanda. We have tested our MMiRNA-Tar tool through analyzing 53 tumor and 11 normal samples of bladder urothelial carcinoma (BLCA) datasets obtained from TCGA and identified 204 microRNAs. These microRNAs were correlated with the mRNAs of five previously-reported bladder cancer risk genes and these selected pairs exhibited correlations in opposite direction between the tumor and normal samples based on the customized cutoff criterion of prediction. Furthermore, we have identified additional 496 genes (830 pairs) potentially targeted by 79 significant microRNAs out of 204 using three cutoff criteria, i.e., false discovery rate (FDR) < 0.1, opposite correlation coefficient between the tumor and normal samples, and predicted by at least one of three target prediction databases. Therefore, MMiRNA-Tar provides researchers a convenient tool to visualize the co-relationship between microRNAs and mRNAs and to predict their targeting relationship. We believe that correlating expression profiles for microRNAs and mRNAs offers a complementary approach for elucidating their interactions.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 25 条
  • [1] Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population
    Hemissi, Imen
    Ayed, Haroun
    Naimi, Zeineb
    Meddeb, Khedija
    Ayadi, Mouna
    Zouari, Skander
    Zaghbib, Selim
    Talbi, Emna
    Chebil, Mohamed
    Ouerhani, Slah
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2021, 9 (11):
  • [2] Genetic Variants in Telomere-Maintenance Genes and Bladder Cancer Risk
    Chang, Joshua
    Dinney, Colin P.
    Huang, Maosheng
    Wu, Xifeng
    Gu, Jian
    PLOS ONE, 2012, 7 (02):
  • [3] Identification of hub genes and pathways in bladder cancer using bioinformatics analysis
    Li, Danhui
    Zhen, Fan
    Le, Jianwei
    Chen, Guodong
    Zhu, Jianhua
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2022, 10 (01): : 13 - 24
  • [4] Genetic variations in Hippo pathway genes influence bladder cancer risk in a Chinese population
    Huang, Zhengkai
    Wang, Xiaolin
    Ma, Lan
    Guo, Zheng
    Liu, Hanting
    Du, Mulong
    Chu, Haiyan
    Wang, Meilin
    Wang, Zengjun
    Zhang, Zhengdong
    ARCHIVES OF TOXICOLOGY, 2020, 94 (03) : 785 - 794
  • [5] Identification of chemoresistance-associated microRNAs and hub genes in breast cancer using bioinformatics analysis
    Wu, Ming
    Zhao, Yujie
    Peng, Nanxi
    Tao, Zuo
    Chen, Bo
    INVESTIGATIONAL NEW DRUGS, 2021, 39 (03) : 705 - 712
  • [6] Identification of chemoresistance-associated microRNAs and hub genes in breast cancer using bioinformatics analysis
    Ming Wu
    Yujie Zhao
    Nanxi Peng
    Zuo Tao
    Bo Chen
    Investigational New Drugs, 2021, 39 : 705 - 712
  • [7] Genetic polymorphisms in the DNA repair genes XPD and XRCC1, p53 gene mutations and bladder cancer risk
    Gao, Weimin
    Romkes, Marjorie
    Zhong, Shilong
    Nukui, Tomoko
    Persad, Raj A.
    Smith, Patrick J. B.
    Branch, Robert
    Keohavong, Phouthone
    ONCOLOGY REPORTS, 2010, 24 (01) : 257 - 262
  • [8] Synthetic artificial "long non-coding RNAs" targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells
    Xie, Haibiao
    Zhan, Hengji
    Gao, Qunjun
    Li, Jianfa
    Zhou, Qun
    Chen, Zhicong
    Liu, Yuhan
    Ding, Mengting
    Xiao, Huizhong
    Liu, Yuchen
    Huang, Weiren
    Cai, Zhiming
    CANCER LETTERS, 2018, 422 : 94 - 106
  • [9] Energy Balance, the PI3K-AKT-mTOR Pathway Genes, and the Risk of Bladder Cancer
    Lin, Jie
    Wang, Jianming
    Greisinger, Anthony J.
    Grossman, H. Barton
    Forman, Michele R.
    Dinney, Colin P.
    Hawk, Ernest T.
    Wu, Xifeng
    CANCER PREVENTION RESEARCH, 2010, 3 (04) : 505 - 517
  • [10] Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes
    Ruan, Xiaohao
    Huang, Da
    Huang, Jingyi
    Tsu, James Hok-Leung
    Na, Rong
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)